» Articles » PMID: 18276599

Mutations in Penicillin-binding Proteins 1, 2 and 3 Are Responsible for Amoxicillin Resistance in Helicobacter Pylori

Overview
Date 2008 Feb 16
PMID 18276599
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To elucidate the relationship between the mutations of penicillin-binding protein (PBP)1, PBP2 and PBP3 and amoxicillin resistance in Helicobacter pylori.

Methods: The mutations detected only in clinical amoxicillin-resistant strains were determined by comparison of the deduced amino acid sequences of PBP1(HP0597), PBP2(HP1556) and PBP3(HP1565) encoded by the pbp1, ftsI and pbp2 genes, respectively, in 13 clinical H. pylori strains and three ATCC strains. The contribution of the mutations in PBPs was analysed by the natural transformation of the amoxicillin-susceptible strain ATCC 700392 with various combinations of the pbp1, ftsI and pbp2 genes from the amoxicillin-resistant strain TH743 (MIC of amoxicillin: 8 mg/L).

Results: We initially identified six, four and two mutations of PBP1, PBP2 and PBP3, respectively, which were detected only in amoxicillin-resistant strains. By the natural transformation of an amoxicillin-susceptible strain ATCC 700392, we found that mutations in PBP1 and PBP3 conferred higher resistance to amoxicillin than mutations in PBP1 and PBP2, or mutations only in PBP1. Furthermore, mutations in PBP1, PBP2 and PBP3 conferred a 256-fold higher amoxicillin resistance when compared with ATCC 700392.

Conclusions: Multiple mutations in PBP2 and PBP3, in addition to mutations in PBP1, confer higher amoxicillin resistance in H. pylori.

Citing Articles

resistance in Hainan Province, China: investigating phenotypes and genotypes through whole-genome sequencing.

Lv Y, Li D, Zhang D, Chen S, Chen R, Wang Y Front Cell Infect Microbiol. 2025; 14:1505166.

PMID: 39742338 PMC: 11685075. DOI: 10.3389/fcimb.2024.1505166.


Whole-genome sequencing analyses and antibiotic resistance situation of 48 Helicobacter pylori strains isolated in Zhejiang, China.

Fang Y, Jiang S, Zhou X, Zhou W, Jiang X, Chen L Gut Pathog. 2024; 16(1):62.

PMID: 39444024 PMC: 11515586. DOI: 10.1186/s13099-024-00656-2.


Clarithromycin sustained-release tablet may be an improper therapy for the eradication of .

Zuo X, Shen Q, Luo J, Wang Y, Zhao C Therap Adv Gastroenterol. 2024; 17:17562848241275332.

PMID: 39290332 PMC: 11406650. DOI: 10.1177/17562848241275332.


Development and validation of next-generation sequencing panel for personalized eradication treatment targeting multiple species.

Min B, Seo M, Bae J, Kim J, Kim J Front Cell Infect Microbiol. 2024; 14:1379790.

PMID: 39268485 PMC: 11390507. DOI: 10.3389/fcimb.2024.1379790.


Comparison of vonoprazan bismuth-containing triple therapy with quadruple therapy in Helicobacter pylori-infected treatment-naive patients: a prospective multicenter randomized controlled trial.

Liang J, Xiong S, Jia Y, Xiao D, Tan S, Cao J J Gastroenterol Hepatol. 2024; 39(11):2293-2298.

PMID: 39013587 PMC: 11618220. DOI: 10.1111/jgh.16679.